1. Home
  2. TWST vs KEN Comparison

TWST vs KEN Comparison

Compare TWST & KEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TWST
  • KEN
  • Stock Information
  • Founded
  • TWST 2013
  • KEN 2014
  • Country
  • TWST United States
  • KEN Singapore
  • Employees
  • TWST N/A
  • KEN N/A
  • Industry
  • TWST Biotechnology: Biological Products (No Diagnostic Substances)
  • KEN Electric Utilities: Central
  • Sector
  • TWST Health Care
  • KEN Utilities
  • Exchange
  • TWST Nasdaq
  • KEN Nasdaq
  • Market Cap
  • TWST 2.3B
  • KEN 2.2B
  • IPO Year
  • TWST 2018
  • KEN N/A
  • Fundamental
  • Price
  • TWST $28.84
  • KEN $45.31
  • Analyst Decision
  • TWST Buy
  • KEN
  • Analyst Count
  • TWST 10
  • KEN 0
  • Target Price
  • TWST $49.10
  • KEN N/A
  • AVG Volume (30 Days)
  • TWST 1.8M
  • KEN 20.0K
  • Earning Date
  • TWST 08-04-2025
  • KEN 09-08-2025
  • Dividend Yield
  • TWST N/A
  • KEN 10.59%
  • EPS Growth
  • TWST N/A
  • KEN N/A
  • EPS
  • TWST N/A
  • KEN 11.35
  • Revenue
  • TWST $362,273,000.00
  • KEN $760,304,000.00
  • Revenue This Year
  • TWST $22.75
  • KEN N/A
  • Revenue Next Year
  • TWST $17.63
  • KEN N/A
  • P/E Ratio
  • TWST N/A
  • KEN $3.88
  • Revenue Growth
  • TWST 22.72
  • KEN 5.78
  • 52 Week Low
  • TWST $24.28
  • KEN $24.10
  • 52 Week High
  • TWST $55.33
  • KEN $49.99
  • Technical
  • Relative Strength Index (RSI)
  • TWST 39.95
  • KEN 54.42
  • Support Level
  • TWST $24.28
  • KEN $42.24
  • Resistance Level
  • TWST $31.20
  • KEN $44.00
  • Average True Range (ATR)
  • TWST 1.97
  • KEN 0.68
  • MACD
  • TWST -0.34
  • KEN -0.49
  • Stochastic Oscillator
  • TWST 35.51
  • KEN 49.12

About TWST Twist Bioscience Corporation

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.

About KEN Kenon Holdings Ltd.

Kenon Holdings Ltd is a holding company that operates dynamic, growth-oriented businesses. The company's operating segments include OPC Power Plants, CPV Group, and ZIM. It generates maximum revenue from the OPC Power Plants segment, which generates and supplies electricity and energy in Israel. CPV Group is a limited partnership owned by OPC, which generates and supplies electricity and energy in the United States. Geographically, the company generates a majority of its revenue from Israel and the rest from the United States.

Share on Social Networks: